XFRA DIVERSE: WIEDERAUFNAHME/RESUMPTION

Realtime	Geld	Brief	Zeit
	75,50	77,00	13:04
	76,00	76,50	26.04.

FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.

THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:

INSTRUMENT NAME KUERZEL/SHORTCODE ISIN
CANADIAN PAC KA.CITY LTD. X88 CA13646K1084
LINCOLN GOLD MINING INC. ZMG CA53359R2054
LION ROCK RES.INC. KGB CA5362502026
MEGAWATT LITH.BATT.METALS WR2 CA58518J2002
PERMEX PETROLEUM 75P CA71422P3034
RIGHT SEASON INV.CORP. T50 CA76658Q2062
SILVER NORTH RESOURCES I90 CA8280611010
WEST MINING CORP. O.N. 1HL0 CA9546062089
CRH PLC EO-,32 CRG IE0001827041
COLLPLANT BIOTECH. IS-,01 CPT IL0004960188
TOP SHIPS DL-,01 UER0 MHY8897Y2307
ATL. BRV. HLDG. C DL-,001 E450 US0477263026
CURIS INC. DL -,01 CUS0 US2312693094
DIANTHUS THERAPEUTICS 87E US2528281080
ELICIO THERAP. DL-,01 9HA US28657F1030
GYRE THERAPEUTICS L9S US4037831033
HARPOON THERAPEUTICS 5HTA US41358P2056
HOWARD HUGHES HOL.INC NEW HHE0 US44267T1025
MARKER THERAPEUTICS INC. GX1 US57055L2060
SINCLAIR INC. A HQ7 US8292421067
SPI.GL.INC. CL.A DL-,0001 EL9 US8485603067
SYNCHRONOSS NEW DL-,0001 H6K0 US87157B4005
VACASA INC. CL.A NEW O.N. W5Q0 US91854V2060
AB/FROM ONWARDS 05.01.2024 14:15 CET

Großer Insider-Report 2024 von Dr. Dennis Riedl

Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.

Hier klicken

	Indizes	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Aktien	Kurs	%	News 24 h / 7 T	Aufrufe 7 Tage


	Xetra-Orderbuch


	Fonds	Kurs	%


	Devisen	Kurs	%


	Rohstoffe	Kurs	%


	Themen	Kurs	%



Erweiterte Suche

Zeit	Aktuelle Nachrichten
11.04.	Atlanta Braves Holdings, Inc. - 8-K, Current Report
02.04.	Buy the Atlanta Braves tracking stock since it will likely be bought by a billionaire, analyst says
01.04.	Atlanta Braves Stock Could Be Undervalued Based On MLB Team Valuations, Did Warren Buffett Spot Another Value Stock?
29.02.	The Liberty Braves Group (BATRA) Q4 2023 Earnings Call Transcript
28.02.	Liberty Braves Series A GAAP EPS of -$0.52, revenue of $67.75M

Zeit	Aktuelle Nachrichten
Do	Canadian Pacific Railway Limited (CP) Q1 2024 Earnings Call Transcript
Do	Canadian Pacific KC (CP) Q1 Earnings Lag Estimates, Up Y/Y
Mi	Canadian Pacific Kansas City Ltd: CPKC shareholders elect 11 directors at AGM
Mi	CP RailKC announces results of director elections
Mi	Why Is Canadian Pacific Kansas City Stock Falling Today?

Zeit	Aktuelle Nachrichten
08.04.	CollPlant Biotechnologies Ltd. (CLGN) Q4 2023 Earnings Call Transcript
04.04.	CollPlant Biotechnologies FY23 Net Loss Narrows
04.04.	CollPlant Biotechnologies GAAP EPS of -$0.62, revenue of $10.96M
04.04.	CollPlant Biotechnologies Ltd - 6-K, Report of foreign issuer
04.04.	CollPlant Biotechnologies Ltd - 20-F, Annual and transition report of foreign private issuers

Zeit	Aktuelle Nachrichten
Do	CRH PLC - Director/PDMR Shareholding
Do	CRH PLC - AGM Statement
Do	CRH regrets difficulties faced by shareholders in US move
Mi	CRH delegation visits Kiev
Mi	CRH plc: CRH Announces Date for Q1 2024 Results Conference Call	CRH plc, the leading provider of building materials solutions, will publish its Q1 2024 financial results on Friday, May 10, 2024 at 2:00 a.m. (New York) 7:00 a.m. (Dublin) followed by a conference... ► Artikel lesen

Zeit	Aktuelle Nachrichten
05.04.	Curis, Inc.: Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)	LEXINGTON, Mass., April 5, 2024 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced... ► Artikel lesen
09.02.	Curis reports positive emavusertib trial results, extends cash runway
09.02.	Earnings call: Curis reports Q4 losses, progresses in oncology trials
08.02.	CURIS INC - S-8, Securities to be offered to employees in employee benefit plans
08.02.	CURIS INC - 10-K, Annual Report

Zeit	Aktuelle Nachrichten
18.04.	What 5 Analyst Ratings Have To Say About Dianthus Therapeutics
11.04.	Dianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual Meeting
05.04.	Dianthus Therapeutics, Inc.: Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NEW YORK and WALTHAM, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. ("Dianthus"), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody... ► Artikel lesen
21.03.	Dianthus Therapeutics reports FY results
21.03.	Dianthus Therapeutics, Inc. /DE/ - S-8, Securities to be offered to employees in employee benefit plans

Zeit	Aktuelle Nachrichten
05.04.	Elicio Therapeutics, Inc.: Elicio Therapeutics to Present Updated Clinical T Cell and Antigen Spreading Response Data from the Ongoing AMPLIFY-201 Phase 1 Study of ELI-002 and Preclinical Data on ELI-007 and ELI-008 at the AACR Annual Meeting
05.04.	Elicio Therapeutics, Inc. - 8-K, Current Report
29.03.	Elicio Therapeutics, Inc. - S-8, Securities to be offered to employees in employee benefit plans
29.03.	Elicio Therapeutics, Inc. - 10-K, Annual Report
29.03.	Elicio Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Zeit	Aktuelle Nachrichten
27.03.	GYRE THERAPEUTICS, INC. - 10-K, Annual Report
26.03.	Gyre Therapeutics GAAP EPS of -$1.41, revenue of $113.5M
26.03.	Gyre Therapeutics Posts Loss In 2023
26.03.	Gyre Therapeutics, Inc.: Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update	Data readout from Phase 3 clinical trial in the People's Republic of China ("PRC") evaluating F351 for the treatment of CHB-associated liver fibrosis expected by early 2025 U.S. Phase 2a clinical... ► Artikel lesen
21.03.	Gyre Therapeutics appoints new board member

CANADIAN PACIFIC KANSAS CITY LIMITED

XFRA DIVERSE: WIEDERAUFNAHME/RESUMPTION